OSE Immunotherapeutics News and Activities

OSE Immunotherapeutics is one of the...

• CAC All-Trade;
• TOB Iconic 10,000.

OSE Immunotherapeutics is a company listed under the stock ticker OSE (FR).

View the org chart displaying its 25 main executives

Most searched biographies at OSE Immunotherapeutics

• Marc Le Bozec, Chief Executive Officer
• Eric Leire, Independent Director
• Markus Cappel, Chairman of the Board

Popular executive movements at OSE Immunotherapeutics

• Nicolas Poirier, Chief Scientific Officer, has left the company  (posted on April 15 2026).
• Aurore Morello, who was Director, Research and Programs, is promoted to Chief Scientific Officer  (posted on April 15 2026).
• Marc Le Bozec who was Interim Chief Executive Officer, becomes Chief Executive Officer  (posted on April 15 2026).

Click here to view some more movements at OSE Immunotherapeutics

Create your alert
to follow the executive moves at OSE Immunotherapeutics.

OSE Immunotherapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by OSE Immunotherapeutics

• Press Releases - OSE Immunotherapeutics

Social media about OSE Immunotherapeutics

• OSE Immunotherapeutics on Wikipedia, Google News & Yahoo Finance
• OSE Immunotherapeutics on LinkedIn, X (Twitter) & YouTube